Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome

Koji Sasaki,Hagop Kantarjian,Guillermo Montalban-Bravo,Danielle Hammond,Elias Jabbour,Rashmi Kanagal-Shamanna,Kelly Chien,Guillermo Garcia-Manero
DOI: https://doi.org/10.1016/j.clml.2024.04.007
2024-04-20
Abstract:Background Lenalidomide is an immunomodulatory therapy used to treat multiple hematologic malignancies. The incidence of eosinophilia and hypereosinophilia during lenalidomide therapy, and the requirement for high-dose steroids are not well-defined Patients and Methods We retrospectively reviewed 44 patients with myelodysplastic syndromes who were treated with lenalidomide therapy from August 2006 and March 2023. Results Eosinophilia (0.5-1.5 × 10 9 /L) and hypereosinophilia (>1.5 × 10 9 /L) were observed in 6 patients (14%) and 4 patients (9%), respectively. The median duration of lenalidomide therapy was 6.5 months. Backward multivariate ordinary logistic regression identified higher absolute eosinophil count (OR, 4759.986; 95% CI, 11.223-2018772.073; P=0.006) and longer duration of lenalidomide therapy (OR, 1.148; 95% CI, 1.012-1.302; P=0.032) as independent prognostic factors for the incidence of eosinophilia and hypereosinophilia. There was a trend for a higher use of high-dose steroids with hypereosinophilia. The median time to develop the first occurrence hypereosinophilia was 0.5 months. Steroids were used in 40% of patients with eosinophilia or hypereosinophilia. All events resolved with discontinuation of lenalidomide and/or use of steroids. No long-tern lasting adverse effects were recorded. Conclusion Lenalidomide may induce or worsen existing eosinophilia which may lead to the need for steroids within a month of therapy. Micro Lenalidomide therapy may be associated with the development of eosinophilia (23%) or hypereosinophilia (9%) in patients with myelodysplastic syndrome. Among patients with eosinophilia, 40% of patients required systemic steroid during lenalidomide therapy.
oncology,hematology
What problem does this paper attempt to address?